CTNNB1 and melanoma: The median OS of patients with APC/CTNNB1-mutant melanomas was significantly shorter than that of patients bearing wild-type APC/CTNNB1 melanomas (8.15 vs. 22.8 months, log-rank HR 4.2, 95CI 1.38–12.58, p = 0.011).